KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Current Deferred Revenue (2017 - 2020)

Historic Current Deferred Revenue for Novartis Ag (NVS) over the last 4 years, with Q4 2020 value amounting to $56.0 million.

  • Novartis Ag's Current Deferred Revenue fell 5087.72% to $56.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $56.0 million, marking a year-over-year decrease of 5087.72%. This contributed to the annual value of $56.0 million for FY2020, which is 5087.72% down from last year.
  • Latest data reveals that Novartis Ag reported Current Deferred Revenue of $56.0 million as of Q4 2020, which was down 5087.72% from $114.0 million recorded in Q4 2019.
  • Novartis Ag's Current Deferred Revenue's 5-year high stood at $305.0 million during Q4 2017, with a 5-year trough of $56.0 million in Q4 2020.
  • Moreover, its 4-year median value for Current Deferred Revenue was $175.0 million (2018), whereas its average is $177.8 million.
  • Per our database at Business Quant, Novartis Ag's Current Deferred Revenue crashed by 2262.3% in 2018 and then crashed by 5169.49% in 2019.
  • Novartis Ag's Current Deferred Revenue (Quarter) stood at $305.0 million in 2017, then dropped by 22.62% to $236.0 million in 2018, then crashed by 51.69% to $114.0 million in 2019, then tumbled by 50.88% to $56.0 million in 2020.
  • Its Current Deferred Revenue stands at $56.0 million for Q4 2020, versus $114.0 million for Q4 2019 and $236.0 million for Q4 2018.